-
XBiotech Inc (NASDAQ: XBIT) shares tumbled 38.9
percent to $10.40 after the company disclosed that the EMA rendered negative trend vote related to MAA for its candidate
antibody for the treatment of colorectal cancer.
-
Adamis Pharmaceuticals Corp (NASDAQ: ADMP) shares
declined 16.5 percent to $3.67. Adamis Pharmaceuticals priced its 4.28 million offering at $3.50 per share.
-
Aevi Genomic Medicine, Inc (NASDAQ: GNMX) shares
dropped 15.1 percent to $1.58. Aevi Genomic Medicine presents updated results from its SAGA trial of AEVI-001 at the 6th World
Congress on ADHD on April 21, 2017.
-
bebe stores, inc. (NASDAQ: BEBE) declined 14.4
percent to $3.22 as the company disclosed that it has entered into consulting agreement to sell all merchandise and inventory,
and also close all its stores.
-
Apricus Biosciences Inc (NASDAQ: APRI) dropped 13
percent to $1.21. Apricus Biosciences priced its offering of 5.03 million units at $1.40 per unit.
-
Onconova Therapeutics Inc (NASDAQ: ONTX) shares
fell 11.7 percent to $2.19. Onconova Therapeutics priced its 2.47 million share offering at $2.10 per share.
-
Clearwater Paper Corp (NYSE: CLW) shares dipped 11.4
percent to $50.50 after the company reported Q1 results. Clearwater Paper reported Q1 adjusted earnings of $0.64 per share on
revenue of $437.5 million.
-
Mattel, Inc. (NASDAQ: MAT) declined 10.4 percent
to $22.59 as the company reported weaker-than-expected results for its first quarter on Thursday.
-
Electronics For Imaging, Inc. (NASDAQ: EFII) fell
9.5 percent to $46.04 after the company reported downbeat quarterly revenue.
-
Fairmount Santrol Holdings Inc (NYSE: FMSA) shares
dropped 9 percent to $5.05. Barclays downgraded Fairmount Santrol from Overweight to Equal-Weight.
-
Cleveland BioLabs, Inc. (NASDAQ: CBLI) shares
dropped 7.7 percent to $3.94 after falling 16.27 percent on Thursday.
-
National Beverage Corp. (NASDAQ: FIZZ) shares
declined 5.8 percent to $85.00. Credit Suisse downgraded National Beverage from Outperform to Neutral.
-
Manhattan Associates, Inc. (NYSE: MANH) shares
slipped 5.4 percent to $47.87. Manhattan Associates posted upbeat quarterly earnings, but sales missed estimates. The company
also cut its FY17 sales outlook.
-
Maxim Integrated Products Inc. (NASDAQ: MXIM)
declined 3.6 percent to $43.83. Maxim Integrated reported Q3 earnings of $0.56 per share on revenue of $581 million. Evercore
ISI Group downgraded the stock from Outperform to In-Line.
-
Immune Pharmaceuticals Inc (NASDAQ: IMNP) fell
3.3 percent to $3.53 after surging 49.59 percent on Thursday.
© 2017 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.